https://www.wsj.com/articles/disney-ceo-iger-need-to-figure-out-disney-pricing-strategy-aa470a0a?mod=e2tw
IMUNON Enters into Collaborative Research Agreement With The Wistar Institute’s Vaccine & Immunotherapy Center To Research IMUNON’s PLACCINE Vaccine Platform
IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, and The Wistar Institute, a global leader in biomedical research located in the heart of University City, Philadelphia, through its Vaccine &